Atturos

Developing new advanced molecular diagnostic solutions to help patients make better decisions.

[UCD Conway Institute @UCD_Conway]

Congratulations to the @atturos team👍who make the list of 23 tech start-ups to watch out for in 2023 https://t.co/mHqjRXsqpE via @siliconrepublic

[Atturos @atturos]

We're thrilled to have been included in @siliconrepublic's list of tech start-ups to watch out for in 2023.

“We have selected some of the most promising Irish start-ups from our series that tech investors and entrepreneurs should keep an eye out for”.

https://t.co/tCiJ8Xy5n0

[Silicon Republic @siliconrepublic]

Atturos: Better diagnostics through machine learning analytics https://t.co/tFlzcr0z80

[UCD Innovation @UCDinnovation]

Excellent profile piece on @atturos as this week’s start-up of the week via @siliconrepublic

[Atturos @atturos]

We’re delighted to have been profiled by @siliconrepublic, updating on our recent activities and future direction. Read our vision for the future of clinical diagnostics, and how we plan to help patients and doctors with their decision-making.

https://t.co/VqvaqnZWDU

[Neoteryx @neoteryx]

#PODCAST: Can you measure proteins in dried serum using Mitra devices w/ #VAMS for #proteomics? What are the economic & logistical advantages vs. liquid sampling? Dr. Steve Pennington explains in this chat w/ Dr. James Rudge, @neoteryx. Listen/read: https://t.co/I1DEZnIvFR

[Atturos @atturos]

Listen to Atturos CSO, @srpennington, discuss the use of microsampling in proteomics & multi-centre studies in the latest @neoteryx microsamplify podcast series.

Together, we are working to investigate microsampling devices for use in protein based advanced diagnostic testing.

[Atturos @atturos]

📢 We are hiring!

Following a very successful year and the recent initiation of major collaborative projects Atturos will be expanding its laboratory operations in 2022.

For more information please visit https://t.co/dqiB9pZQZh

#ClinicalProteomics #TeamMassSpec

[GRAPPA Network - Official @GrappaO]

¿Biomarkers in PsA? Check out Abst#0449 by @ColemanOrla which was highlighted as an Oral Presentation.
** 69 proteins that can potentially discriminate PsA patients who will progress to radiographic damage from those who will not.
#ACR21 #GRAPPA

[Nelly ZIADE 🍀 @Nellziade]

#SpA session #ACR21
Biomarkers to predict radiographic progression in active #psoriatic_arthritis
Clinical data alone is not enough
@ColemanOrla

#ACRambassador

[Nelly ZIADE 🍀 @Nellziade]

Join us at the #SpA #CommunityHub #ACR21
🟣When? Tomorrow Saturday, Nov 6 | 12:00 pm ET
🟣Who? Meet the speakers @ColemanOrla @Atturos @MarkCHwang @MrtTrgtlp & Dr.Raychaudhuri
🟣What? SpA Clinical Oral Presentations
#ACRambassador

[Hippocrates-IMI @Hippocrates_IMI]

Today is #WorldArthritisDay! #PsoriaticArthritis is a chronic inflammatory disease affecting the musculoskeletal system & the skin. In #HIPPOCRATES, 26 partners have joined forces to develop innovative personalised treatment options for people affected by the disease. #Time2Work

[UCD Medicine @UCDMedicine]

Warm wishes Steve Pennington, Chief Scientific Officer @atturos spin-out co @ucddublin on DISTINGUISHED SERVICE AWARD @hupo_org (Human Proteome Org)

Steve was HUPO Pres 2019-20 with input over previous yrs. Focus on inclusivity & early career researchers https://t.co/4ewbCncwWK

[Atturos @atturos]

Oliver FitzGerald (Atturos Clinical Leadership Team and @GrappaO Co-President) has been recognised as a Master of the @ACRheum. This is one of the highest honours the College bestows to members who have made outstanding contributions to the field.

Congratulations Oliver!

[Atturos @atturos]

WEBINAR: The Agilent and Atturos pathway for the development of targeted biomarker measurements for precision medicine

For those of you who couldn't make it, you can playback the recording here: https://t.co/DX7XNCawAg

[Atturos @atturos]

.@srpennington (Atturos CSO) and Oliver Fitzgerald (Atturos Clinical Leadership Team and GRAPPA President) were joined by senior scientists @jcwaddi and @ColemanOrla to present project updates at the international @GrappaO 2021 meeting.

View here: https://t.co/zZV1zxmcUo

[Atturos @atturos]

Atturos CSO @srpennington leads research published in Arthritis & Rheumatology

Read our latest publication “Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis”

https://t.co/CztjkCsRbW

[Atturos @atturos]

We're delighted to announce Atturos is to play a key role in #HIPPOCRATESproject - a new €21m EU and industry funded research project combining 26 partners in promoting early identification and improving outcomes for patients with #PsoriaticArthritis.

https://t.co/fGdlWTM1xM

[NovaUCD @NovaUCD]

Making it Work: Medical #startup @Atturos gets €700k for arthritic research https://t.co/ISclBZ3fMo via @businessposthq and @DonalMacNamee97

@UCDMedicine @UCD_Conway @UCD_Research

@Entirl @DisruptiveEI @EI_HPSU

[Dr. Claire Tonry @tonryc]

Exciting news from my PhD supervisor's spin-out company @atturos, providing advanced diagnostic solutions for improved treatment of #psoriaticarthritis #HIPPOCRATES #diagnostics #proteomics https://t.co/G5NIeQk46j